Cardiff Oncology, Inc.
CRDF· Nasdaq
Filed Mar 30, 2012 · 10-K · 90 days after period end · 0001104659-12-022906
derived · Computed from the longer spans the company filed.
no prior Q4 2010 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2011 · filed Mar 30, 2012 · 90 d after period end
Cardiff Oncology, Inc. · CIK 1213037 · Engraved from SEC EDGAR